Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Possible role of new pressor protein in hypertensive anephric hemodialysis patients.

Pearl RJ, Papageorgiou PC, Goldman M, Amfilochiadis AA, Boomsma F, Rojkjaer R, Geary D, Osmond DH.

Pediatr Nephrol. 2003 Oct;18(10):1025-31. Epub 2003 Aug 12. Erratum in: Pediatr Nephrol. 2003 Dec;18(12):1319.

PMID:
12920630
3.

Are cardiovascular and sympathoadrenal effects of human "new pressor protein" preparations attributable to human coagulation beta-FXIIa?

Papageorgiou PC, Pourdjabbar A, Amfilochiadis AA, Diamandis EP, Boomsma F, Osmond DH.

Am J Physiol Heart Circ Physiol. 2004 Mar;286(3):H837-46. Epub 2003 Oct 23.

4.

Coagulation factor XIIa-kinin-mediated contribution to hypertension of chronic kidney disease.

Papageorgiou PC, Chan CT, Yeo EL, Backx PH, Floras JS.

J Hypertens. 2014 Jul;32(7):1523-33; discussion 1533. doi: 10.1097/HJH.0000000000000192.

PMID:
24733030
5.

Potent blood pressure raising effects of activated coagulation factor XII.

Mavrogiannis L, Kariyawasam KP, Osmond DH.

Can J Physiol Pharmacol. 1997 Dec;75(12):1398-403.

PMID:
9534952
6.

The sympathoadrenal system mediates the blood pressure and cardiac effects of human coagulation factor XII-related "new pressor protein".

Mavrogiannis L, Trambakoulos DM, Boomsma F, Osmond DH.

Can J Cardiol. 2002 Oct;18(10):1077-86.

PMID:
12420043
7.
8.
9.

Role of bradykinin B2-receptor in the sympathoadrenal effects of 'new pressor protein' related to human blood coagulation factor XII fragment.

Amfilochiadis AA, Papageorgiou PC, Kogan N, Boomsma F, Osmond DH.

J Hypertens. 2004 Jun;22(6):1173-81.

PMID:
15167453
10.
11.
12.

Further studies on the existence of a sensitizing factor to pressor agents in hypertension.

Michelakis AM, Mizukoshi H, Huang C, Murakami K, Inagami T.

J Clin Endocrinol Metab. 1975 Jul;41(1):90-6.

PMID:
1150866
13.

Blood pressure regulation in end-stage renal disease and anephric man.

Onesti G, Kim KE, Greco JA, del Guercio ET, Fernandes M, Swartz C.

Circ Res. 1975 Jun;36(6 Suppl 1):145-52.

PMID:
1093752
14.

A year-long quality improvement project on fluid management using blood volume monitoring during hemodialysis.

Balter P, Ficociello LH, Taylor PB, Usvyat L, Sawin DA, Mullon C, Diaz-Buxo J, Zabetakis P.

Curr Med Res Opin. 2015;31(7):1323-31. doi: 10.1185/03007995.2015.1047746. Epub 2015 Jun 3.

PMID:
25942380
15.

Angiotensin-II and endothelin-1 levels in children with renoprival hypertension.

Seguias L, Zilleruelo G, Strauss J, Abitbol C, Montane B.

Pediatr Nephrol. 2001 Jun;16(6):493-6.

PMID:
11420913
16.

Which dialysis unit blood pressure is the most accurate for predicting home blood pressure in patients undergoing hemodialysis?

Yoon IC, Choi HM, Oh DJ.

Korean J Intern Med. 2017 Jan;32(1):117-124. doi: 10.3904/kjim.2015.278. Epub 2016 Apr 7.

17.

Effect of sympathetic and plasma renin activity on hemodialysis hypertension.

Grekas D, Kalevrosoglou I, Karamouzis M, Geropoulou E, Kabouris H, Tourkantonis A.

Clin Nephrol. 2001 Feb;55(2):115-20.

PMID:
11269674
18.

Vascular renin-like activity and blood pressure.

Basso N, Kurnjek ML, Taquini AC.

Mayo Clin Proc. 1977 Jul;52(7):437-41.

PMID:
875467
19.

Prevalence of hypertension in a hemodialysis population.

Mittal SK, Kowalski E, Trenkle J, McDonough B, Halinski D, Devlin K, Boylan E, Flaster E, Maesaka JK.

Clin Nephrol. 1999 Feb;51(2):77-82.

PMID:
10069642
20.

Ambulatory blood pressure monitoring and peri-hemodialysis blood pressures in a southeast US hemodialysis unit.

Fülöp T, Schmidt DW, Cosmin A, Islam N, Wells C, Lengvárszky Z, Bilbrew DM, Zsom L.

Clin Nephrol. 2012 May;77(5):383-91.

PMID:
22551884

Supplemental Content

Support Center